Literature DB >> 13821950

Duration of survival in multiple myeloma.

M FEINLEIB, B MACMAHON.   

Abstract

Entities:  

Keywords:  MYELOMA, PLASMA CELL/statistics

Mesh：

Year:  1960        PMID： 13821950

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  10 in total

1.  MYELOMATOSIS AND ITS TREATMENT.

Authors:  N K KOCHETKOV; I G ZHUKOVA; I S GLUKHODED
Journal:  Br Med J       Date:  1964-04-04

2.  [DURATION OF DISEASE AND SURVIVAL TIME IN MULTIPLE MYELOMA].

Authors:  P OBRECHT; E KALLITERAKIS; D KLEMM
Journal:  Klin Wochenschr       Date:  1963-09-15

3.  A randomized multicentric study comparing alternating combination chemotherapy (VCMP/VBAP) and melphalan-prednisone in multiple myeloma.

Authors:  J Bladé; J San Miguel; A Alcalá; J Maldonado; J García-Conde; M J Moro; M A Sanz Sanz; C Alonso; A Zubizarreta; C Besses
Journal:  Blut       Date:  1990-06

Review 4.  Immunocytoma o' mice an' men.

Authors:  J R Hobbs
Journal:  Br Med J       Date:  1971-04-10

5.  [The beginning plasmacytoma].

Authors:  H Brücher
Journal:  Blut       Date:  1974-02

6.  Factors influencing the prognosis in myelomatosis.

Authors:  A A Dawson; D Ogston
Journal:  Postgrad Med J       Date:  1971-10       Impact factor: 2.401

Review 7.  Protein analyses in myelomatosis.

Authors:  P M Carter; L Slater; J Lee; D Perry; J R Hobbs
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1975

8.  [Life prognosis of treated and non-treated patients with plasmacytoma].

Authors:  C Ramsbott; H Gerhartz; P Obrecht
Journal:  Blut       Date:  1967-01

9.  [Analysis of prognostic factors in plasmacytoma].

Authors:  W Gassmann; T Haferlach; N Schmitz; W Kayser; H H Euler; J Drews; H Löffler
Journal:  Klin Wochenschr       Date:  1984-10-01

Review 10.  The treatment of multiple myeloma--an important MRC trial.

Authors:  P W Johnson; P J Selby
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.